Rothschild Investment LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rothschild Investment LLC’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4K	Sell	25 -5	-17%	-$2.56K	﹤0.01%	1724
2026 Q1	$15.7K	Buy	30 +6	+25%	+$2.87K	﹤0.01%	1510
2025 Q4	$14K	Hold	24	–	–	﹤0.01%	1456
2025 Q3	$11K	Sell	24 -3	-11%	-$1.12K	﹤0.01%	1404
2025 Q2	$8.17K	Sell	27 -6	-18%	-$1.79K	﹤0.01%	1299
2025 Q1	$10.9K	Buy	33 +13	+65%	+$4.27K	﹤0.01%	1149
2024 Q4	$6.17K	Buy	20 +3	+18%	+$844	﹤0.01%	1280
2024 Q3	$3.61K	Buy	17 +11	+183%	+$2.81K	﹤0.01%	1417
2024 Q2	$1.68K	Buy	6 +5	+500%	+$1.19K	﹤0.01%	1451
2024 Q1	$267	Buy	+1	New	+$236	﹤0.01%	1612

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rothschild Investment LLC's MDGL Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Madrigal Pharmaceuticals (MDGL) stake by 17% in Q2 2026, selling an estimated $2.56K and leaving 25 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Rothschild Investment LLC first reported a position in MDGL in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.7K in Q1 2026. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Rothschild Investment LLC held 25 shares of Madrigal Pharmaceuticals worth $13.4K as of Q2 2026.
Rothschild Investment LLC sold 5 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $2.56K.
Madrigal Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1724 holding.
Rothschild Investment LLC first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Rothschild Investment LLC's Madrigal Pharmaceuticals position peaked at $15.7K in Q1 2026.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.